As of Q4'25, UnitedHealth Group (UNH) reported an EPS of 2.40 USD, marking a significant decline compared to previous quarters. The year-over-year EPS growth for this period stands at -60.27%, highlighting a sharp contraction in earnings performance. From Q1'23 to Q4'25, the EPS trend for UNH has been highly volatile, with notable fluctuations across quarters. After relatively stable and positive EPS values through 2023, the company experienced a dramatic drop to -1.53 USD in Q1'24, followed by a partial recovery and new highs in Q1'25 at 6.90 USD. However, the latter half of 2025 shows a pronounced downward trajectory, with both EPS and YoY growth turning negative, indicating increased earnings pressure and potential operational challenges.